SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 2132421

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132421

Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Androgenetic Alopecia, Traction Alopecia, Cicatricial Alopecia), By Treatment Type, By Gender, By Sales Channel, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Alopecia Market Summary

The global alopecia market size was valued at USD 53.3 billion in 2025 and is projected to grow from USD 56.8 billion in 2026 to USD 100.6 billion by 2033, at a CAGR of 8.5% from 2026 to 2033. Asia Pacific dominated the market, accounting for a revenue share of 33.6% in 2025.The global alopecia market is supported by the increasing clinical burden of hair loss disorders, broader access to dermatology services, and the availability of prescription therapies for different forms of alopecia.

Androgenetic alopecia remains the most common indication, affecting a substantial proportion of adult men and women worldwide, while autoimmune conditions such as alopecia areata continue to generate demand for targeted treatment options. Clinical diagnosis has improved through the wider use of dermoscopy, scalp imaging, and standardized severity assessment, enabling earlier treatment decisions. The market is also supported by growing patient awareness of medical management rather than cosmetic approaches, particularly in developed healthcare systems. Product development activity has expanded beyond topical therapies to include oral treatments, biologics, and Janus kinase (JAK) inhibitors for immune-mediated hair loss. Regulatory approvals in major markets have strengthened physician confidence in prescribing targeted therapies, while ongoing clinical studies continue to evaluate additional therapeutic pathways for different alopecia subtypes and disease severity.

Market expansion is supported by continued investment from pharmaceutical companies, dermatology-focused biotechnology firms, and specialty healthcare providers. Companies are advancing both novel molecular targets and lifecycle management strategies for existing products, with clinical programs addressing efficacy, long-term safety, and broader patient populations. Increased collaboration between biotechnology companies and larger pharmaceutical organizations has strengthened late-stage development and global commercialization capabilities. The integration of teledermatology platforms has improved patient access to specialist consultations, follow-up care, and prescription management, particularly for chronic hair loss conditions requiring long-term monitoring. At the same time, regulatory agencies continue to evaluate additional treatment options through established approval pathways, expanding the range of evidence-based therapies available to clinicians. Although treatment affordability, variable clinical response, and limited reimbursement remain considerations in several countries, continued research activity, expanding clinical evidence, and greater recognition of alopecia as a medical condition are supporting sustained development of the global alopecia market.

Global Alopecia Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global alopecia market report based on disease type, treatment type, gender, sales channel, and region:

  • Disease Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Alopecia Areata
  • Androgenetic Alopecia
  • Traction Alopecia
  • Cicatricial (Scarring) Alopecia
  • Others
  • Treatment Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Minoxidil
  • Finasteride & Dutasteride
  • Corticosteroids
  • JAK Inhibitors
  • Other Pharmaceuticals
  • Platelet-Rich Plasma (PRP)
  • Low-Level Laser Therapy (LLLT) Devices
  • Hair Transplant Procedures
  • Gender Outlook (Revenue, USD Million, 2021 - 2033)
  • Male
  • Female
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Specialty Clinics / Direct Dispensing
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-856-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease Type
    • 1.2.2. Treatment Type
    • 1.2.3. Gender
    • 1.2.4. Sales Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Alopecia Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Alopecia Market: Disease Type Business Analysis

  • 4.1. Disease Type Market Share, 2025 & 2033
  • 4.2. Disease Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2021 to 2033 (USD Million)
  • 4.4. Alopecia Areata
    • 4.4.1. Alopecia Areata Market, 2021 - 2033 (USD Million)
  • 4.5. Androgenetic Alopecia
    • 4.5.1. Androgenetic Alopecia Market, 2021 - 2033 (USD Million)
  • 4.6. Traction Alopecia
    • 4.6.1. Traction Alopecia Market, 2021 - 2033 (USD Million)
  • 4.7. Cicatricial (Scarring) Alopecia
    • 4.7.1. Cicatricial (Scarring) Alopecia Market, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Alopecia Market: Treatment Type Business Analysis

  • 5.1. Treatment Type Market Share, 2025 & 2033
  • 5.2. Treatment Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Treatment Type, 2021 to 2033 (USD Million)
  • 5.4. Minoxidil
    • 5.4.1. Minoxidil Market, 2021 - 2033 (USD Million)
  • 5.5. Finasteride & Dutasteride
    • 5.5.1. Finasteride & Dutasteride Market, 2021 - 2033 (USD Million)
  • 5.6. Corticosteroids
    • 5.6.1. Corticosteroids Market, 2021 - 2033 (USD Million)
  • 5.7. JAK Inhibitors
    • 5.7.1. JAK Inhibitors Market, 2021 - 2033 (USD Million)
  • 5.8. Other Pharmaceuticals
    • 5.8.1. Other Pharmaceuticals, 2021 - 2033 (USD Million)
  • 5.9. Platelet-Rich Plasma (PRP)
    • 5.9.1. Platelet-Rich Plasma (PRP) Market, 2021 - 2033 (USD Million)
  • 5.10. Low-Level Laser Therapy (LLLT) Devices
    • 5.10.1. Low-Level Laser Therapy (LLLT) Devices Market, 2021 - 2033 (USD Million)
  • 5.11. Hair Transplant Procedures
    • 5.11.1. Hair Transplant Procedures Market, 2021 - 2033 (USD Million)

Chapter 6. Alopecia Market: Gender Business Analysis

  • 6.1. Gender Market Share, 2025 & 2033
  • 6.2. Gender Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Gender, 2021 to 2033 (USD Million)
  • 6.4. Male
    • 6.4.1. Male Market, 2021 - 2033 (USD Million)
  • 6.5. Female
    • 6.5.1. Female Market, 2021 - 2033 (USD Million)

Chapter 7. Alopecia Market: Sales Channel Business Analysis

  • 7.1. Sales Channel Market Share, 2025 & 2033
  • 7.2. Sales Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2021 to 2033 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Retail Pharmacies Market, 2021 - 2033 (USD Million)
  • 7.5. Hospital Pharmacies
    • 7.5.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
  • 7.6. Online Pharmacies
    • 7.6.1. Online Pharmacies Market, 2021 - 2033 (USD Million)
  • 7.7. Specialty Clinics / Direct Dispensing
    • 7.7.1. Specialty Clinics / Direct Dispensing Market, 2021 - 2033 (USD Million)

Chapter 8. Alopecia Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America Alopecia Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Framework
      • 8.4.2.5. U.S. Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Framework
      • 8.4.3.5. Canada Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Framework
      • 8.4.4.5. Mexico Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Framework
      • 8.5.2.5. UK Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Framework
      • 8.5.3.5. Germany Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Framework
      • 8.5.4.5. France Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Framework
      • 8.5.5.5. Italy Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Framework
      • 8.5.6.5. Spain Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement Framework
      • 8.5.7.5. Denmark Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Target Disease Prevalence
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement Framework
      • 8.5.8.5. Sweden Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Target Disease Prevalence
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement Framework
      • 8.5.9.5. Norway Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Framework
      • 8.6.2.5. Japan Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Framework
      • 8.6.3.5. China Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Framework
      • 8.6.4.5. India Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Framework
      • 8.6.5.5. Australia Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement Framework
      • 8.6.6.5. South Korea Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Target Disease Prevalence
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement Framework
      • 8.6.7.5. Thailand Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Framework
      • 8.7.2.5. Brazil Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Framework
      • 8.7.3.5. Argentina Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East and Africa
    • 8.8.1. Middle East and Africa Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Target Disease Prevalence
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement Framework
      • 8.8.2.5. South Africa Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Target Disease Prevalence
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement Framework
      • 8.8.3.5. Saudi Arabia Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Target Disease Prevalence
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement Framework
      • 8.8.4.5. UAE Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Target Disease Prevalence
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement Framework
      • 8.8.5.5. Kuwait Alopecia Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Pfizer Inc.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Eli Lilly and Company
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Organon & Co.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Johnson & Johnson
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Viatris Inc.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. EmCyte Corporation
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Regen Lab SA
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Terumo Corporation
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Zimmer Biomet Holdings, Inc.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Arthrex, Inc
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
    • 9.5.11. Bosley Inc.
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic Initiatives
    • 9.5.12. DHI Global Medical Group
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial Performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic Initiatives
    • 9.5.13. Asmed Hair Transplant Center
      • 9.5.13.1. Overview
      • 9.5.13.2. Financial Performance
      • 9.5.13.3. Product Benchmarking
      • 9.5.13.4. Strategic Initiatives
    • 9.5.14. Bernstein Medical
      • 9.5.14.1. Overview
      • 9.5.14.2. Financial Performance
      • 9.5.14.3. Product Benchmarking
      • 9.5.14.4. Strategic Initiatives
    • 9.5.15. Hairline International Hair and Skin Clinic
      • 9.5.15.1. Overview
      • 9.5.15.2. Financial Performance
      • 9.5.15.3. Product Benchmarking
      • 9.5.15.4. Strategic Initiatives
Show more
Product Code: 978-1-68038-856-5

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Alopecia market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 5. Global Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 6. Global Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 7. Global Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 8. North America Alopecia market, by country, 2021 - 2033 (USD Million)
  • Table 9. North America Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 10. North America Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 11. North America Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 12. North America Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 13. U.S. Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 14. U.S. Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 15. U.S. Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 16. Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 17. Canada Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 18. Canada Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 19. Canada Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 20. Canada Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 21. Mexico Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 22. Mexico Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 23. Mexico Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 24. Mexico Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 25. Europe Alopecia market, by country, 2021 - 2033 (USD Million)
  • Table 26. Europe Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 27. Europe Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 28. Europe Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 29. Europe Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 30. UK Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 31. UK Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 32. UK Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 33. UK Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 34. Germany Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 35. Germany Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 36. Germany Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 37. Germany Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 38. France Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 39. France Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 40. France Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 41. France Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 42. Italy Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 43. Italy Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 44. Italy Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 45. Italy Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 46. Spain Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 47. Spain Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 48. Spain Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 49. Spain Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 50. Norway Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 51. Norway Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 52. Norway Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 53. Norway Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 54. Denmark Alopecia market, by Disease type, 2021 - 2033 (USD Million)
  • Table 55. Denmark Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 56. Denmark Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 57. Denmark Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 58. Sweden Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 59. Sweden Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 60. Sweden Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 61. Sweden Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 62. Asia Pacific Alopecia market, by country, 2021 - 2033 (USD Million)
  • Table 63. Asia Pacific Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 64. Asia Pacific Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 65. Asia Pacific Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 66. Asia Pacific Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 67. Japan Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 68. Japan Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 69. Japan Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 70. Japan Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 71. China Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 72. China Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 73. China Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 74. China Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 75. India Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 76. India Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 77. India Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 78. India Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 79. Australia Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 80. Australia Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 81. Australia Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 82. Australia Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 83. South Korea Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 84. South Korea Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 85. South Korea Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 86. South Korea Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 87. Thailand Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 88. Thailand Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 89. Thailand Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 90. Thailand Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 91. Latin America Alopecia market, by country, 2021 - 2033 (USD Million)
  • Table 92. Latin America Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 93. Latin America Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 94. Latin America Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 95. Latin America Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 96. Brazil Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 97. Brazil Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 98. Brazil Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 99. Brazil Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 100. Argentina Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 101. Argentina Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 102. Argentina Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 103. Argentina Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 104. Middle East & Africa Alopecia market, by country, 2021 - 2033 (USD Million)
  • Table 105. Middle East & Africa Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 106. Middle East & Africa Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 107. Middle East & Africa Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 108. Middle East & Africa Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 109. South Africa Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 110. South Africa Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 111. South Africa Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 112. South Africa Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 113. Saudi Arabia Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 114. Saudi Arabia Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 115. Saudi Arabia Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 116. Saudi Arabia Alopecia market, by sales channel, 2021 - 2033 (USD Million)
  • Table 117. UAE Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 118. UAE Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 119. UAE Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 120. UAE Alopecia market, sales channel, 2021 - 2033 (USD Million)
  • Table 121. Kuwait Alopecia market, by disease type, 2021 - 2033 (USD Million)
  • Table 122. Kuwait Alopecia market, by treatment type, 2021 - 2033 (USD Million)
  • Table 123. Kuwait Alopecia market, by gender, 2021 - 2033 (USD Million)
  • Table 124. Kuwait Alopecia market, by sales channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Alopecia market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape
  • Fig. 10 Alopecia market dynamics
  • Fig. 11 Alopecia market: Porter's five forces analysis
  • Fig. 12 Alopecia market: PESTLE analysis
  • Fig. 13 Disease Type market, 2021 - 2033 (USD Million)
  • Fig. 14 Alopecia Areata market, 2021 - 2033 (USD Million)
  • Fig. 15 Androgenetic Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 16 Traction Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 17 Cicatricial (Scarring) Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Treatment Type market, 2021 - 2033 (USD Million)
  • Fig. 20 Minoxidil market, 2021 - 2033 (USD Million)
  • Fig. 21 Finasteride & Dutasteride market, 2021 - 2033 (USD Million)
  • Fig. 22 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 23 JAK Inhibitors market, 2021 - 2033 (USD Million)
  • Fig. 24 Other Pharmaceuticals market, 2021 - 2033 (USD Million)
  • Fig. 25 Platelet-Rich Plasma (PRP) market, 2021 - 2033 (USD Million)
  • Fig. 26 Low-Level Laser Therapy (LLLT) Devices market, 2021 - 2033 (USD Million)
  • Fig. 27 Hair Transplant Procedures market, 2021 - 2033 (USD Million)
  • Fig. 28 Gender market, 2021 - 2033 (USD Million)
  • Fig. 29 Male market, 2021 - 2033 (USD Million)
  • Fig. 30 Female market, 2021 - 2033 (USD Million)
  • Fig. 31 Sales Channel market, 2021 - 2033 (USD Million)
  • Fig. 32 Retail Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 33 Hospital Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 34 Online Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 35 Alopecia market revenue, by region
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 North America Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. country dynamics
  • Fig. 39 U.S. Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 40 Canada country dynamics
  • Fig. 41 Canada Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico country dynamics
  • Fig. 43 Mexico Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 45 UK country dynamics
  • Fig. 46 UK Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 47 Germany country dynamics
  • Fig. 48 Germany Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 49 France country dynamics
  • Fig. 50 France Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 51 Italy country dynamics
  • Fig. 52 Italy Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 53 Spain country dynamics
  • Fig. 54 Spain Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 55 Norway country dynamics
  • Fig. 56 Norway Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 57 Sweden country dynamics
  • Fig. 58 Sweden Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark country dynamics
  • Fig. 60 Denmark Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 62 Japan country dynamics
  • Fig. 63 Japan Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 64 China country dynamics
  • Fig. 65 China Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 66 India country dynamics
  • Fig. 67 India Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 68 Australia country dynamics
  • Fig. 69 Australia Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 70 South Korea country dynamics
  • Fig. 71 South Korea Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 72 Thailand country dynamics
  • Fig. 73 Thailand Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 74 Latin America Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 75 Brazil country dynamics
  • Fig. 76 Brazil Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 77 Argentina country dynamics
  • Fig. 78 Argentina Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 79 MEA Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa country dynamics
  • Fig. 81 South Africa Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia country dynamics
  • Fig. 83 Saudi Arabia Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 84 UAE country dynamics
  • Fig. 85 UAE Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait country dynamics
  • Fig. 87 Kuwait Alopecia market, 2021 - 2033 (USD Million)
  • Fig. 88 Company categorization
  • Fig. 89 Company market position analysis
  • Fig. 90 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!